Report on methiopropamine (MPA)

Document type
Advisory Council on the Misuse of Drugs
Date of publication
18 November 2015
Substance Misuse
Social welfare
Material type

Download (80KB )

This report recommends that a temporary class drug order be placed on this new psychoactive substance due to its risk of acute harm. The report provides information on the chemistry and pharmacology, prevalence of use and acute harm risks of misuse of the substance.  MPA is a stimulant novel psychoactive substance (NPS) which is similar in structure to methamphetamine.  In 2014, seven cases were reported where MPA was implicated in death, albeit in combination with a variety of other NPS. The Advisory Council on the Misuse of Drugs (ACMD) therefore recommends that it be subject to a Temporary Class Drug Order (TCDO) and be treated as a Schedule 1 drug in applying the provisions of the Misuse of Drugs Regulations.

Related to Substance Misuse

Drug misuse and dependence: UK guidelines on clinical management

Downloadable guidelines on treating people with drug misuse and drug dependence problems

Family drug and alcohol court national unit: independent evaluation: research report

The family drug and alcohol court (FDAC) offers an alternative form of care proceedings for children put at risk of significant…

Fourth addendum to ACMD’s report on synthetic cannabinoids

This addendum recommends revisions to the regulations regarding the scheduling of synthetic cannabinoids. Specifically, they…

More items related to this subject